Audinga-Dea Hazewinkel

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Top Venues

Current oncology (Toronto, Ont.)

Biometrical journal. Biometrische Zeitschrift

Computational and mathematical methods in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Spreafico, Audinga-Dea Hazewinkel, André B P van Kuilenburg, Marta Fiocco
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data. Current oncology (Toronto, Ont.) 31 (7) (2024)
Marta Spreafico, Audinga-Dea Hazewinkel, Michiel Adreanus van de Sande, André B P van Kuilenburg, Marta Fiocco
Machine Learning versus Cox Models for Predicting Overall Survival in Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data. Cancers 16 (16) (2024)
Marta Spreafico, Audinga-Dea Hazewinkel, André B P van Kuilenburg, Marta Fiocco
Dynamic Prediction of Overall Survival for Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data. Current oncology (Toronto, Ont.) 31 (7) (2024)
Marta Spreafico, Audinga-Dea Hazewinkel, Michiel Adreanus van de Sande, André B P van Kuilenburg, Marta Fiocco
Machine Learning versus Cox Models for Predicting Overall Survival in Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data. Cancers 16 (16) (2024)
Audinga-Dea Hazewinkel, Kate Tilling, Kaitlin H Wade, Tom M Palmer
Trial arm outcome variance difference after dropout as an indicator of missing-not-at-random bias in randomized controlled trials. Biometrical journal. Biometrische Zeitschrift (2023)
Georgios Kantidakis, Audinga-Dea Hazewinkel, Marta Fiocco
Neural Networks for Survival Prediction in Medicine Using Prognostic Factors: A Review and Critical Appraisal. Computational and mathematical methods in medicine 2022 (2022)
Audinga-Dea Hazewinkel, Jack Bowden, Kaitlin H Wade, Tom M Palmer, Nicola J Wiles, Kate Tilling
Sensitivity to missing not at random dropout in clinical trials: Use and interpretation of the trimmed means estimator. Statistics in medicine 41 (8) (2022)
Audinga-Dea Hazewinkel, Carlo Lancia, Jakob Anninga, Michiel van de Sande, Jeremy S Whelan, Hans Gelderblom, Marta Fiocco
Disease progression in osteosarcoma: a multistate model for the EURAMOS-1 (European and American Osteosarcoma Study) randomised clinical trial. BMJ open 12 (3) (2022)